ArticlebioRxiv : the preprint server for biology2026
RNase 4 improves bottom-up modification mapping of
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The structural and functional diversity of RNAs is expanded by the post-transcriptional incorporation of nucleoside variants. Emblematic of this, tRNAs contain extensive modifications that ensure their function during protein synthesis. Mass spectrometry has long been the field standard for identifying specific sites of chemical modifications on RNA. Nonetheless, mass spectrometry-based mapping approaches are not widely implemented. This is partially due to technical challenges associated with current methodologies including the limited diversity of available RNases, complexity of RNA mixtures, and conventional use ion-pairing reagents that require dedicated instrumentation. Here, we present a bottom-up liquid chromatography-tandem mass spectrometry (LC-MS/MS) workflow employing hydrophilic interaction liquid chromatography (HILIC) without ion-pairing reagents to globally map
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.